首页> 外文期刊>Clinical kidney journal. >Adenine phosphoribosyltransferase (APRT) deficiency: a new genetic mutation with early recurrent renal stone disease in kidney transplantation
【24h】

Adenine phosphoribosyltransferase (APRT) deficiency: a new genetic mutation with early recurrent renal stone disease in kidney transplantation

机译:腺嘌呤磷酸核糖基转移酶(APRT)缺陷:肾移植肾肾病早期复发的新基因突变。

获取原文
获取外文期刊封面目录资料

摘要

Adenine phosphoribosyltransferase (APRT) deficiency, a rare inborn error inherited as an autosomic recessive trait, presents with 2,8-dihydroxyadenine (2,8-DHA) crystal nephropathy. We describe clinical, biochemical and molecular findings in a renal transplant recipient with renal failure, 2,8-DHA stones and no measurable erythrocyte APRT activity. Homozygous C??G substitution at ?3 in the splicing site of exon 2 (IVS2 ?3 c??g) was found in the APRT gene. The patient's asymptomatic brother was heterozygous for such mutation, and his APRT activity was 23% of controls. A splicing alteration leading to incorrect gene transcription and virtually absent APRT activity is seemingly associated with the newly identified mutation.
机译:腺嘌呤磷酸核糖基转移酶(APRT)缺乏症是一种罕见的先天性遗传,是常染色体隐性遗传,它伴有2,8-二羟基腺嘌呤(2,8-DHA)结晶性肾病。我们描述了肾衰竭,2,8-DHA结石且无可测量的红细胞APRT活性的肾移植受者的临床,生化和分子发现。在APRT基因中发现了外显子2的剪接位点的第3位的纯合的C 3>≥G的取代(IVS2≤3c>≥g)。该患者的无症状兄弟是这种突变的杂合子,其APRT活性为对照的23%。似乎导致新的突变的剪接改变导致基因转录不正确和APRT活性实际上缺失。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号